Sponsor Dossier
Celltrion Healthcare
Sponsor Dossier for Celltrion Healthcare. ARTG portfolio, PBS-listed brands, PBAC activity, AusPAR record — compiled by arcimedes.
- Brand: AVTOZMA
- Brand: EYDENZELT
- Brand: HERZUMA
- Brand: OMLYCLO
- Brand: OSENVELT
- Brand: REMSIMA
- Brand: STEQEYMA
- Brand: STOBOCLO
- Device (sponsor): Skin-cleaning wipe, sterile
- Device (sponsor): Antiseptic swab
About
Celltrion Healthcare is an Australian Private Company with ABN 66625407105, registered in NSW and currently active.
Portfolio
Celltrion Healthcare has 11 brands on the ARTG, with 11 indexable brands and 10 brands with Product Information on file. Of the portfolio, 5 brands are PBS-listed, 6 brands have PBAC outcomes on record, and 6 brands have AusPARs on record.
Therapeutic focus —
Immunology: 4 brands — Oncology: 4 brands — Ophthalmology: 1 brand — Infectious Disease: 1 brand — Endocrinology: 1 brand
PBS footprint
Five brands in the Celltrion Healthcare portfolio are PBS-listed, with the latest PBS schedule date touched on 1 May 2026.
Regulatory activity
The most recent PBAC outcome for Celltrion Healthcare was on 1 November 2025, with 6 brands holding PBAC outcomes on record. The most recent AusPAR was dated 8 May 2025, with 6 brands holding AusPARs on record.